TRPV2 is overexpressed by a variety of cancer cells and plays a functional role in hepatocellular carcinoma, prostate cancer, bladder cancer, and glioblastoma development (Liu et al., 2010; Monet et al., 2010; Nabissi et al., 2013). This evidence concerns the gene TRPV2 and hepatocellular carcinoma.